Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center

Molecular Pathology

The University of Colorado Cancer Center Molecular Pathology Shared Resource ensures that well-characterized human tumors and materials derived from human tumors are provided to Cancer Center and other funded investigators for research in human cancer. 

The three complementary services in the Molecular Pathology Shared Resource provide fundamental
technologies for CU Cancer Center researchers, including DNA sequencing, biospecimen evaluation and preparation, and cytogenetics analysis. Having expertise in these molecular research essentials greatly facilitates cancer research in Colorado.

Cytogenetics Service

Cytogenetics Service

The CU Cancer Center Cytogenetics Service is a source of expertise on experimental design, data analyses and interpretation and is equipped with state-of-the-art fluorescence microscopes and performs karyotyping and custom-based FISH assays.

Learn about our cytogenetics services

DNA Sequencing Service

DNA Sequencing & Analysis Service

The focus and mission of the DNA Sequencing & Analysis Service is to provide reliable DNA sequencing data rapidly to its customers. This goal is accomplished using state-of-the-art capillary DNA sequencing instruments. 

Learn about our DNA Sequencing & Analysis Service

Preanalytical Evaluation and Molecular Testing Service

Preanalytical Evaluation and Molecular Testing Service

The Pre-analytical Evaluation and Molecular Testing (PEMT) Service provides processing, testing, imaging and verification services to support basic laboratory and clinical research.

Discover our preanalytical evaluation and molecular testing service

University of Colorado Denver

© The Regents of the University of Colorado, a body corporate. All rights reserved.

All trademarks are registered property of the University. Used by permission only.